CLINICAL STAGE III CUTANEOUS MELANOMA AJCC V8
Clinical trials for CLINICAL STAGE III CUTANEOUS MELANOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new CLINICAL STAGE III CUTANEOUS MELANOMA AJCC V8 trials appear
Sign up with your email to follow new studies for CLINICAL STAGE III CUTANEOUS MELANOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail shows promise against advanced melanoma before surgery
Disease control CompletedThis study tested whether giving a combination of targeted drugs (vemurafenib and cobimetinib) and an immunotherapy (atezolizumab) before surgery could help patients with high-risk stage III melanoma. 64 adults with advanced melanoma that had spread to lymph nodes took part. The …
Matched conditions: CLINICAL STAGE III CUTANEOUS MELANOMA AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 26, 2026 04:36 UTC
-
New program aims to ease cancer survivors' distress and improve follow-up care
Knowledge-focused CompletedThis study tested a program designed to help adolescent and young adult cancer survivors (ages 15-39) find healthcare resources, learn self-care skills, and get support. The goal was to see if the program could reduce cancer-related distress and help survivors follow recommended …
Matched conditions: CLINICAL STAGE III CUTANEOUS MELANOMA AJCC V8
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC